China Neurology Devices Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented By Type of Device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device and Other Type of Devices)

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors augmenting the growth of the neurology devices market includes increasing incidences of neurological disorders, technological advancements and increase in R&D in the field of neurotherapies. Major neurological disorders include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, spinal cord tumor, and stroke. According to World Health Organizations (WHO), among neurological disorders, Alzheimer’s disease and other dementias accounts for around 2.84% of the total number of deaths in high-income countries. The rising number of patients with neurological disorders, lead to high demand for early diagnosis of neurological conditions. Additionally, the increasing awareness among patients is expected to augment the neurology devices market.

Scope of the report

As per the scope of the report, Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson’s disease, major depression, and traumatic brain injury.

By Type of Device
Cerebrospinal Fluid Management Device
Interventional Neurology Device
Interventional/Surgical Simulators
Neurothrombectomy Devices
Carotid Artery Stents
Neurosurgery Device
Neuroendoscopes
Aneurysm Clip
Other Neurosurgery Devices
Neurostimulation Device
Spinal Cord Stimulation Device
Deep Brain Stimulation Device
Sacral Nerve Stimulation Device
Other Neurostimulation Devices
Other Type of Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cerebrospinal Fluid Management Segment is Expected to Show Better Growth in the Forecast Years

Based on type of device, it is segmented into cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device and other type of devices. Cerebral spinal fluid (CSF) shunt systems are used to treat hydrocephalus, which is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. The CSF imbalance can lead to elevated intracranial pressure (ICP), which can lead to a variety of complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. The need for diagnosis and treatment of neurological disorders have made significant progress in recent years, which is expected to drive the market growth in the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The major players in the China neurology devices market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Neurological Disorders

      2. 4.2.2 Technological Advancements in Neurology Devices

      3. 4.2.3 Increase in R&D in the Field of Neurotherapies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

      2. 4.3.2 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Device

      1. 5.1.1 Cerebrospinal Fluid Management Device

      2. 5.1.2 Interventional Neurology Device

        1. 5.1.2.1 Interventional/Surgical Simulators

        2. 5.1.2.2 Neurothrombectomy Devices

        3. 5.1.2.3 Carotid Artery Stents

      3. 5.1.3 Neurosurgery Device

        1. 5.1.3.1 Neuroendoscopes

        2. 5.1.3.2 Aneurysm Clip

        3. 5.1.3.3 Other Neurosurgery Devices

      4. 5.1.4 Neurostimulation Device

        1. 5.1.4.1 Spinal Cord Stimulation Device

        2. 5.1.4.2 Deep Brain Stimulation Device

        3. 5.1.4.3 Sacral Nerve Stimulation Device

        4. 5.1.4.4 Other Neurostimulation Devices

      5. 5.1.5 Other Type of Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Johnson and Johnson

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 MicroPort Scientific

      7. 6.1.7 Nihon Kohden Corporation

      8. 6.1.8 Smith & Nephew plc

      9. 6.1.9 Stryker Corporation

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports